In CRC, a number of studies have addressed the prognostic and predictive value of c-MYC and MET gene alterations applying different criteria, such as the target gene/corresponding CEP signal ratio of ≥2–3 for amplification and the target GCN gain of ≥4 copies [12–15]. Here, MET is linked to colorectal carcinoma.